Clinical Trials for Peripheral T Cell Lymphoma

Find clinical trials for peripheral t cell lymphoma. Discover research opportunities and treatment options in your area.

34 Active Trials Found

Showing 34 trials on this page

Page 2 of 2

Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

NCT ID: NCT06509945

This clinical trial is studying a treatment called allogeneic peripheral blood stem cell transplantation for patients with high-risk peripheral T-cell lymphoma (PTCL). The goal is to see how effect...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

NCT ID: NCT06433362

This clinical trial is studying a new treatment called CMOEP for patients with untreated peripheral T-cell lymphoma, a type of blood cancer. The researchers want to find out how safe and effective ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)

NCT ID: NCT05934864

The TRUST trial is a study designed to learn more about different types of Peripheral T-cell Lymphoma (PTCL), a type of cancer that affects the lymphatic system. Researchers want to understand how ...

Recruiting

Type: observational Locations: Beijing, , China, Shandong, , China +4 more

Genotype-guided Treatment in Newly Diagnosed PTCL

NCT ID: NCT05675813

This clinical trial is looking at a new way to treat patients with a type of cancer called Peripheral T-cell Lymphoma (PTCL). The study has two main parts: the first part will help researchers dete...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

NCT ID: NCT03719105

This clinical trial is exploring new treatment options for young patients with aggressive types of blood cancers called NK-cell lymphoma and leukemia, as well as certain types of peripheral T-cell ...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Valhalla, New York, United States, Columbus, Ohio, United States +4 more

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

NCT ID: NCT05923502

The CHANT study is looking into the use of Duvelisib, a medication in capsule form, for treating various types of non-Hodgkin's lymphoma (NHL), which is a type of cancer that affects the lymphatic ...

Not yet recruiting

Type: observational

Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas

NCT ID: NCT06089941

This clinical trial is focused on studying a new method for analyzing circulating tumor DNA (ctDNA) in patients with peripheral T-cell lymphoma (PTCL). The goal is to see if this approach can help ...

Not yet recruiting

Type: observational Locations: Rouen, , France

Phase I/II Study of Linperlisib Plus Chidamide for R/R Peripheral T-cell Lymphoma: a Prospective, Multi-center Study

NCT ID: NCT06083701

This clinical trial is looking at a new combination treatment for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), which is a type of cancer that affects the lymphatic system...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China, Beijing, Beijing, China +1 more

Transplantation After Complete Response In Patients With T-cell Lymphoma

NCT ID: NCT05444712

This clinical trial is investigating the use of autologous stem cell transplantation (ASCT) for patients with Peripheral T-cell lymphoma (PTCL) who have achieved a complete response to their initia...

Recruiting

Phase: NA Type: interventional Locations: Rouen, , France, Lyon, , France +49 more

Go-CHOP as the Frontline Therapy for PTCL

NCT ID: NCT05963347

The Go-CHOP clinical trial is studying a new combination treatment for patients with Peripheral T-Cell Lymphoma (PTCL), a type of cancer that affects the immune system. This trial is looking at how...

Recruiting

Phase: PHASE2 Type: interventional Locations: Zhengzhou, Henan, China, Zhengzhou, Henan, China

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

NCT ID: NCT05979792

This clinical trial is studying a new treatment option for patients with a type of cancer called peripheral T-cell lymphoma (PTCL) that has either come back after treatment or has not responded to ...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Zhengzhou, Henan, China, Shanghai, , China +6 more

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

NCT ID: NCT05900089

This clinical trial is studying a new treatment called SHR0302 for patients with a type of cancer known as peripheral T/NK cell lymphoma, which has either returned after treatment or didn’t respond...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Zhengzhou, Henan, China

A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

NCT ID: NCT05559008

This clinical trial is looking at new targeted treatments for patients with a type of cancer called Peripheral T-cell lymphoma, specifically for those whose disease has come back after initial trea...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

NCT ID: NCT04489264

This clinical trial is investigating whether a treatment called autologous stem cell transplantation (ASCT) can improve outcomes for patients with a type of cancer known as peripheral T-cell lympho...

Recruiting

Type: observational Locations: Beijing, , China, Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions